Summary: July 19 (Bloomberg) -- Bloomberg News reporter Shannon Pettypiece discusses approval of Gilead Sciences Inc.'s HIV treatment drug Truvada, by the Food and Drug Administration. Pettypiece talks with Bloomberg's Pimm Fox and Courtney Donohoe on Bloomberg Radio's "Taking Stock." (Source: Bloomberg)
